XML 45 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Securities
12 Months Ended
Dec. 31, 2022
Securities  
Securities

Note 3:   Securities

The amortized cost and approximate fair values, together with gross unrealized gains and losses of securities are as follows:

    

    

Gross

    

Gross

    

Amortized

Unrealized

Unrealized

Cost

Gains

Losses

Fair Value

(In thousands)

Available-for-sale Securities:

 

  

 

  

 

  

 

  

December 31, 2022:

 

  

 

  

 

  

 

  

U.S. government agencies

$

45,000

$

$

(968)

$

44,032

Subordinated notes

31,160

(3,066)

28,094

State and municipal obligations

152,447

459

(7,408)

145,498

Total debt securities

$

228,607

$

459

$

(11,442)

$

217,624

Available-for-sale Securities:

 

 

 

 

December 31, 2021:

 

 

 

 

U.S. government agencies

$

$

$

$

Subordinated notes

28,837

76

(148)

28,765

State and municipal obligations

106,533

11,015

117,548

Total debt securities

$

135,370

$

11,091

$

(148)

$

146,313

There were no sales of investment securities during 2022. During 2021, the Company sold $11.4 million of State and Municipal securities for a total gain of approximately $1,250,000.

The amortized cost and fair value of available-for-sale securities at December 31, 2022, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties.

    

Amortized

    

Fair

Cost

Value

(In thousands)

One to five years

$

45,651

$

44,484

Five to ten years

 

33,440

30,414

Over ten years

 

149,516

142,726

Totals

$

228,607

$

217,624

The carrying value of securities pledged as collateral, to secure public deposits and for other purposes, was $68.7 million and $64.4 million at December 31, 2022 and 2021, respectively.

Certain investments in debt securities are reported in the financial statements at an amount less than their historical cost. The total fair value of these investments at December 31, 2022 and 2021, was $166.1 million and $14.2 million, which represented approximately 76% and approximately 10%, respectively, of the Company’s available-for-sale investment portfolio.

Based on evaluation of available evidence, including recent changes in market interest rates, credit rating information and information obtained from regulatory filings, management believes the declines in fair value for these securities are temporary.

The following tables show the Company’s investments’ gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31, 2022 and 2021:

December 31, 2022

Less than 12 Months

12 Months or More

Total

Description of

    

Fair

    

Unrealized

    

Fair

    

Unrealized

    

Fair

    

Unrealized

Securities

Value

Losses

Value

Losses

Value

Losses

(In thousands)

US government agencies

$

44,032

$

(968)

$

$

$

44,032

$

(968)

Subordinated notes

11,185

(1,565)

10,300

(1,501)

21,485

(3,066)

State and municipal obligations

100,599

(7,408)

100,599

(7,408)

Total temporarily impaired securities

$

155,816

$

(9,941)

$

10,300

$

(1,501)

$

166,116

$

(11,442)

December 31, 2021

Less than 12 Months

12 Months or More

Total

Description of

    

Fair

    

Unrealized

    

Fair

    

Unrealized

    

Fair

    

Unrealized

Securities

Value

Losses

Value

Losses

Value

Losses

(In thousands)

US government agencies

$

$

$

$

$

$

Subordinated notes

14,204

(148)

14,204

(148)

State and municipal obligations

Total temporarily impaired securities

$

14,204

$

(148)

$

$

$

14,204

$

(148)

The unrealized losses on the Company’s investments in US government agencies, state and municipal obligations, and subordinated notes were caused by interest rate increases. Because the Company does not intend to sell the investments and it is not more likely than not the Company will be required to sell the investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at December 31, 2022.